Table 8.
The globulin content (g/L).
| Groups | 1 dpi | 4 dpi | 8 dpi |
|---|---|---|---|
| Uninfected-untreated control | 12.78 ± 0.85 a | 12.92 ± 0.69 a | 11.76 ± 0.87 a |
| Infected-untreated control | 12.78 ± 0.86 a | 16.94 ± 1.38 b | 16.10 ± 0.58 b |
| ShiYingZi-PL | 13.9 ± 2.09 a | 17.42 ± 0.53 b | 16.98 ± 1.65 b |
| ShiYingZi-PM | 13.18 ± 1.45 a | 16.84 ± 0.3 b | 17.58 ± 0.89 b |
| ShiYingZi-PH | 13.00 ± 0.74 a | 17.96 ± 0.8 b | 16.82 ± 1.5 b |
| Monensin | 12.8 ± 1.31 a | 17.04 ± 0.78 b | 16.68 ± 0.9 b |
| ShiYingZi-TL | 12.93 ± 1.77 a | 16.57 ± 2.57 b | 15.73 ± 1.65 b |
| ShiYingZi-TM | 12.20 ± 0.46 a | 17.17 ± 0.83 b | 15.83 ± 2.94 b |
| ShiYingZi-TH | 12.70 ± 1.97 a | 15.47 ± 1.76 b | 18.03 ± 0.80 b |
| Sulfachloropyrazine sodium | 12.73 ± 1.83 a | 16.47 ± 1.56 b | 16.37 ± 0.86 b |
a,b,c Significant differences exist when there are different letters in each column (p < 0.05). n = 5.